Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Clinical Hematology International
|
November 25, 2021
High Sensitivity Troponin T and NT-proBNP in Patients Receiving Chimeric Antigen Receptor (CAR) T-Cell Therapy
Jiun-Ruey Hu, Ameet Patel, Shi Huang, et al.
Diabetes Care
|
November 7, 2020
The Effect of Standard Versus Longer Intestinal Bypass on GLP-1 Regulation and Glucose Metabolism in Patients With Type 2 Diabetes Undergoing Roux-en-Y Gastric Bypass: The Long-Limb Study
Alexander Dimitri Miras, Anna Kamocka, Belén Pérez-Pevida, et al.
Blood Advances
|
April 14, 2022
Patient-specific comorbidities as prognostic variables for survival in myelofibrosis
Andrew L Sochacki, Cosmin Adrian Bejan, Shilin Zhao, et al.
Blood
|
December 2, 2024
Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma
Hun Ju Lee, Rod Ramchandren, Judah Friedman, et al.
The Lancet. Diabetes & Endocrinology
|
May 11, 2020
Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery
Francesco Rubino, Ricardo V Cohen, Geltrude Mingrone, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Clinical Hematology International
|
November 25, 2021
High Sensitivity Troponin T and NT-proBNP in Patients Receiving Chimeric Antigen Receptor (CAR) T-Cell Therapy
Jiun-Ruey Hu, Ameet Patel, Shi Huang, et al.
Diabetes Care
|
November 7, 2020
The Effect of Standard Versus Longer Intestinal Bypass on GLP-1 Regulation and Glucose Metabolism in Patients With Type 2 Diabetes Undergoing Roux-en-Y Gastric Bypass: The Long-Limb Study
Alexander Dimitri Miras, Anna Kamocka, Belén Pérez-Pevida, et al.
Blood Advances
|
April 14, 2022
Patient-specific comorbidities as prognostic variables for survival in myelofibrosis
Andrew L Sochacki, Cosmin Adrian Bejan, Shilin Zhao, et al.
Blood
|
December 2, 2024
Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma
Hun Ju Lee, Rod Ramchandren, Judah Friedman, et al.
The Lancet. Diabetes & Endocrinology
|
May 11, 2020
Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery
Francesco Rubino, Ricardo V Cohen, Geltrude Mingrone, et al.
Page
of 3